Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diflunisal for familial amyloid polyneuropathy
2006-001066-16Phase 2Completed
- Sponsor
- John L. Berk, M.D.
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in familial amyloid polyneuropathy (FAP) comparing Diflunisal with Placebo (2 arms). Primary endpoint: Neurologic Impairment Score (NIS+7). Started Nov 2006; status: completed.
02
Drugs
diflunisal
03
Conditions
familial amyloid polyneuropathy (FAP)
Beyond the preview
Go deeper on 2006-001066-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001066-16.